Filing Details
- Accession Number:
- 0001127602-22-025948
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-17 16:29:05
- Reporting Period:
- 2022-11-15
- Accepted Time:
- 2022-11-17 16:29:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1783992 | R Kevin Thornal | 250 Campus Drive Marlborough MA 01752 | Group Pres, Global Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-15 | 6,628 | $75.37 | 62,368 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-11-15 | 12,490 | $40.85 | 74,858 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-11-15 | 12,490 | $75.30 | 62,368 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2022-11-15 | 12,490 | $0.00 | 12,490 | $40.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-12-01 | No | 4 | M | Direct |
Footnotes
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.35 to $75.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.26 to $75.372 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, December 1, 2017.
Billionaire Hedge Funds
